Apollo Hospitals, INE437A01024

Apollo Hospitals stock: Q2 growth lifts revenue and margins

Published on 11/13/2026 at 02:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Apollo Hospitals reported stronger Q2 FY27 revenue and profit as occupancy and patient volumes improved. Expansion plans remain on track.

Strong second-quarter operating momentum

  • Apollo Hospitals reported 23 percent revenue growth in Q2 FY27, supported by higher patient volumes and improved occupancy.
  • Hospital expansion remains central, with around 5,800 beds planned over the next five years.
  • The 470-bed Gurugram facility is scheduled for commissioning in Q3 FY27.
Apollo Hospitals, INE437A01024, Illustration mit AI erstellt.

Apollo Hospitals Enterprise reported stronger operating performance for the July-September quarter, with growth across hospitals, pharmacy and digital healthcare. The results were released on November 4, 2026, and summarized by Medical Buyer on November 5.

Consolidated revenue rose 23 percent year on year to INR 76.15 billion in Q2 FY27. EBITDA increased 28.8 percent to INR 11.91 billion, while the EBITDA margin improved to 15.6 percent from 14.9 percent a year earlier. Medical Buyer reported net profit of INR 6.60 billion, while the companys investor-relations materials identify the period as Q2 FY27.

Hospitals lead quarterly growth

Apollo's healthcare services business generated revenue of INR 39.00 billion, up 23 percent. Occupancy improved to 73 percent from 69 percent, inpatient volumes increased 14 percent and average revenue per occupied bed rose 8 percent to INR 186,880. International patient services revenue increased 37 percent.

Apollo HealthCo, which includes pharmacy distribution and digital healthcare, increased revenue 23 percent to INR 32.86 billion. EBITDA rose to INR 1.93 billion from INR 1.10 billion, while the pharmacy network reached 7,662 stores after 222 additions during the quarter. Apollo Health and Lifestyle revenue increased 20 percent to INR 4.29 billion.

Expansion remains the next test

The group plans to add around 5,800 beds over five years. Its 470-bed Gurugram facility remains on track for commissioning in Q3 FY27, while newer hospitals in Pune, Hyderabad, Delhi, Kolkata and Bengaluru are being ramped up. For investors, execution at these facilities and continued occupancy gains are key operating factors for the second half of FY27.

Current stock quotation

Apollo Hospitals stock traded at 8,515 Indian rupees on the NSE at 3:29 p.m. IST on Thursday, November 12, 2026. The quotation was 1.03 percent below the previous session close of 8,604 Indian rupees.

Apollo Hospitals Enterprise Limited

  • ISIN: INE437A01024
  • Exchange: NSE
  • Latest quotation: 8,515 Indian rupees on November 12, 2026, at 3:29 p.m. IST
  • Previous session close: 8,604 Indian rupees
  • Business: Hospitals, pharmacy distribution, digital healthcare, diagnostics and related healthcare services
  • Registered office: Chennai, India

Indian equities remain the relevant market backdrop for Apollo Hospitals. See the Current market reports.

More news and analyses on Apollo Hospitals stock.

Disclaimer...
en | INE437A01024 | APOLLO HOSPITALS | boerse | 70501538 | bgmi